About the AuthorMy name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market.
My ProfileI am an authority on regulatory aspects of communications and medical products, with particular emphasis on pre-approval communications; strategist to help pharma and biotech companies prepare best case for advisory committee approval; and counselor in issues and crisis management. I am a frequent speaker on various aspects of same - drug development, promotion, reimbursement and new media in a highly regulated environment. Author of books, newspaper and magazine pieces related to drug marketing and promotion as well as HIV specialty pieces. And of course... blogger!
About This BlogEye on FDA is published by Mark Senak of FleishmanHillard's Washington, D.C. office. The thoughts and ideas in this blog and postings are strictly my own and are not screened by my employer. Everything posted on this blog is my personal opinion and does not necessarily represent the views of FleishmanHillard or its clients.
Posts by Date
My Favorite Dogs
Monthly Archives: March 2010
Hello from Berlin again! Truly one of the highlights of the entire two day ExL 2nd Annual Digital Pharma Europe conference was a presentation by Dr. Bertalan Mesko from the University of Debrecen, Medical School and Health Science Center who … Continue reading
Hello from Berlin! The Second Annual Digital Pharma ExL Conference began today at Bayer-Schering headquarters in Berlin, Germany. It has been a great experience for me to see where Europe is compared to the U.S. and I hope … Continue reading
Robert Pear at the New York Times reported this weekend that President Obama was set to nominate DonM. Berwick as the new head of the the Center for Medicare and Medicaid Services (CMS). Don Berwick is currently the President and … Continue reading
Wow. Last week's Weekly Roundup expressed some skepticism that health care reform would actually happen over the following weekend. And this week's Roundup begins with a sigh of relief that it is all over. By the way, I tweeted yesterday … Continue reading